Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Revenue
Vivos Therapeutics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Revenue
$13.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
Vivos Therapeutics Inc
Revenue Breakdown
Breakdown by Geography
Vivos Therapeutics Inc
Breakdown by Segments
Vivos Therapeutics Inc
Total Revenue:
13.8m
USD
|
Service:
7.5m
USD
|
Product:
6.3m
USD
|
Appliance Sales To Vip:
6.1m
USD
|
Vip:
3.9m
USD
|
Sleep Testing Services:
1.2m
USD
|
Billing Intelligence Services:
887k
USD
|
Myofunctional Therapy Services:
861k
USD
|
Sponsorship Seminar Other:
676k
USD
|
Center Revenue:
189k
USD
|
See Also
What is Vivos Therapeutics Inc's Revenue?
Revenue
13.8m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Revenue amounts to 13.8m USD.
What is Vivos Therapeutics Inc's Revenue growth rate?
Revenue CAGR 5Y
29%
Over the last year, the Revenue growth was -14%. The average annual Revenue growth rates for Vivos Therapeutics Inc have been 2% over the past three years , 29% over the past five years .